We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
San Francisco, Calif-based prescription digital therapeutics company Blue Note Therapeutics has teamed up with clinical trial administrator Curebase for a “virtual” clinical trial to reach patients with cancer-related distress. Read More
Immunodiagnostics developer Oncimmune has inked a contract with Alphabet subsidiary Verily Life Sciences to conduct autoantibody profiling on patients who have developed long COVID-19, defined as a symptomatic case of COVID-19 that lasts for more than four weeks. Read More
A clinical trial of KidneyIntelX’s Renalytix chronic kidney disease diagnostic tool showed that it can accurately forecast the rate of patients’ decline in kidney function, the company said. Read More
Irvine, Calif.-based enVVeno Medical has released promising data from a first-in-human study of its VenoValve implant for the treatment of chronic venous insufficiency (CVI). Read More
An international trial evaluating Elixir Medical’s DynamX Bioadaptor drug-eluting coronary artery implant has completed enrollment of 444 patients across 35 centers in Japan, Europe and New Zealand, the company said. Read More
Clearwater, Fla.-based Apyx Medical’s Renuvion dermal handpiece with the company’s helium plasma technology for dermal resurfacing succeeded in treating wrinkles in a clinical trial, researchers reported in the journal Lasers in Surgery and Medicine. Read More
Patients with nonsurgical refractory back pain (NSRBP) treated with Nevro’s Senza high-frequency 10-kHz spinal cord stimulation (SCS) device saw a significant improvement in a clinical trial. Read More
Therma Bright said it is “the first company in the COVID-19 diagnostic testing space to successfully complete a 15-minute rapid antigen saliva-based U.S. study.” Read More
An international investigational trial of India-based Sahajanand Medical Technologies’ self-expanding transcatheter aortic heart valve (THF) system, Hydra, showed the implanted system performed well after one year. Read More
A late-stage trial of BioCardia’s CardiAMP cell therapy system for heart failure has passed a milestone, with the independent data safety monitoring board recommending that the study continue as designed. Read More
Patients using Boston, Mass.-based Myomo’s MyoPro powered arm and hand brace showed statistically significant improvements in motor function in a pilot study, according to new research published in the journal Frontiers in Neurology. Read More